Study guide
9.1 IWGDF Risk Stratification Categories and Surveillance Intervals
NAWCCB Diabetic Wound Certified DWC
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Foot Anatomy and Wound-Healing Physiology
1.1 Structural Anatomy of Plantar and Dorsal Skin, Subcutaneous Tissue, and Plantar Fat Pads 1.2 Osseous, Ligamentous, and Vascular Anatomy of the Foot 1.3 Cellular Phases of Wound Healing and Diabetic Pathophysiologic Impairments 1.4 Nail Unit and Periungual Anatomy Relevant to Diabetic Foot Care 1.5 Functional Neurovascular and Tendon Anatomy of the Foot
2 Chapter 2: Etiology and Pathogenesis of Diabetic Foot Ulcers
2.1 Pathogenesis and Clinical Manifestations of Diabetic Neuropathies 2.2 Peripheral Artery Disease and Microvascular Dysfunction in Diabetes 2.3 The Ulcer Triad: Repetitive Mechanical Stress, Deformity, and Unperceived Trauma
3 Chapter 3: Diagnostic Assessment: Sensory and Biomechanical Testing
3.1 Sensory Assessment and Loss of Protective Sensation (LOPS) 3.2 Biomechanical Assessment, Structural Foot Deformities, and Plantar Pressure Analysis 3.3 Diagnosis and Differential of Acute and Chronic Charcot Neuroarthropathy 3.4 Performance and Interpretation of TBI, Toe PPG, TcPO₂, and Skin Temperature Testing 3.5 Procedural Skills: Nail Trimming and Conservative Sharp Debridement 3.6 Procedural Skills: Total Contact Casting and Residual-Limb Wrapping
4 Chapter 4: Diagnostic Assessment: Vascular, Laboratory, and Imaging Studies
4.1 Bedside Noninvasive Vascular Diagnostics 4.2 Laboratory Evaluation: Inflammatory Markers, Glycemic Control, Nutritional Indices, and Renal Function 4.3 Microbiologic Diagnostics: Deep Tissue Curettage vs. Superficial Swabs, Bone Biopsy, and Culture Interpretation 4.4 Imaging of the Diabetic Foot: Plain Radiographs, Probe-to-Bone Test, MRI, and Nuclear Scintigraphy for Osteomyelitis
5 Chapter 5: Comprehensive Examination and Ulcer Classification
5.1 Patient History, Dermatologic Inspection, and Nail Pathology 5.2 Ulcer Assessment: Measurements, Tissue Characteristics, Exudate, Edges, Undermining, and Tunneling 5.3 Diabetic Foot Ulcer Classification Systems: Wagner Scale and University of Texas System 5.4 PEDIS, IWGDF/IDSA Staging, and SINBAD Classification Systems in Clinical Practice 5.5 Structured Medical, Foot, Medication, Family, and Psychosocial History 5.6 Dermatologic Examination: Diabetic Dermatoses and Nail Disorders 5.7 Structural Foot, Gait, Footwear, Insole, and Sock Examination
6 Chapter 6: Wound Bed Preparation, Debridement, and Advanced Dressings
6.1 Wound Bed Preparation (TIME Principle) and Debridement Modalities 6.2 Exudate Management and Topical Dressings in Diabetic Wound Care 6.3 Advanced Wound Modalities: Negative Pressure Wound Therapy and Cellular/Tissue-Based Products 6.4 Hyperbaric Oxygen Therapy, Biophysical Modalities, and Revascularization Indications 6.5 Treatment of Xerosis, Fissures, Nail Disorders, and Callus 6.6 Individualized Nutrition and Pain Management in Diabetic Foot Care 6.7 The Unsalvageable Foot: Amputation Decisions, Perioperative Care, and Rehabilitation
7 Chapter 7: Offloading Strategies and Biomechanical Interventions
7.1 Offloading Biomechanics and the Gold Standard: Total Contact Casting and Non-Removable Knee-High Devices 7.2 Removable Cast Walkers, Orthotic Walkers, Half-Shoes, and Wedge Offloading 7.3 Surgical Interventions for Pressure Relief: Tendon Lengthening, Metatarsal Head Resection, and Tenotomies
8 Chapter 8: Infection Management and Antimicrobial Stewardship
8.1 Clinical Diagnosis and Severity Grading of Diabetic Foot Infections 8.2 Empiric and Targeted Antimicrobial Therapy, Route Selection, and Antimicrobial Stewardship 8.3 Medical and Surgical Management of Diabetic Foot Osteomyelitis
9 Chapter 9: Prevention Strategies, Patient Education, and Multidisciplinary Care
9.1 IWGDF Risk Stratification Categories and Surveillance Intervals 9.2 Patient and Caregiver Education: Daily Inspection, Hygiene, Temperature Monitoring, and Avoidance of Self-Care Hazards 9.3 Prescription Therapeutic Footwear, Custom Insoles, Depth Shoes, and Rocker Soles 9.4 The Multidisciplinary Diabetic Foot Team: Core Specialties, Communication, and Urgent Referral Triggers 9.5 Annual Screening and Treatment of Pre-Ulcerative Signs 9.6 Metabolic Risk Reduction, Nutrition, Glucose Management, and Safe Activity 9.7 Inclusive Education, Ethical Care, Legal Duties, and Apparent Nonadherence
9.1 IWGDF Risk Stratification Categories and Surveillance Intervals
Key Takeaways Explain This Topic AI
The International Working Group on the Diabetic Foot (IWGDF) Risk Stratification System assigns patients with diabetes to one of four risk tiers (Categories 0 through 3) based on the presence of Loss of Protective Sensation (LOPS), Peripheral Artery Disease (PAD), foot deformities, prior ulceration, amputation, and end-stage renal disease.
Category 0 denotes very low risk (no LOPS, no PAD) requiring annual foot examination, while Category 1 denotes low risk (isolated LOPS or isolated PAD without deformity) requiring clinical surveillance every 6 to 12 months.
Category 2 indicates moderate risk (LOPS + PAD, LOPS + structural foot deformity, or PAD + structural foot deformity) mandating active clinical surveillance every 3 to 6 months.
Category 3 represents high risk (LOPS or PAD plus at least one of: history of prior diabetic foot ulcer, prior lower-extremity amputation, or end-stage renal disease on dialysis) requiring intensive surveillance every 1 to 3 months.
A standardized surveillance encounter requires 10-g Semmes-Weinstein monofilament testing, palpation of pedal pulses, dermatologic inspection for pre-ulcerative calluses and fissures, assessment for osseous deformities, and objective evaluation of current footwear and orthoses.
Last updated: September 2026
Clinical Rationale and Evolution of IWGDF Risk Stratification
Diabetic foot ulceration is rarely an unpredictable or spontaneous event. Rather, it represents the cumulative endpoint of a recognizable triad: peripheral neuropathy, structural or biomechanical deformity, and unperceived repetitive mechanical trauma. Because the development of sensory loss, vascular insufficiency, and soft tissue breakdown progresses along an identifiable trajectory, preventative medicine relies on systematic risk stratification. The International Working Group on the Diabetic Foot (IWGDF) established a globally recognized, evidence-based risk classification system designed to categorize patients based on their specific risk of developing a primary or recurrent foot ulcer and to link each risk tier to a defined clinical surveillance frequency.
Historically, diabetic foot examinations were performed sporadically, often prompted only after a patient or caregiver observed drainage or systemic signs of sepsis. Implementing systematic risk stratification converts reactive wound treatment into proactive limb preservation. By identifying patients harboring pre-ulcerative lesions, subclinical ischemia, or sensory denervation, clinicians can introduce targeted offloading, customized footwear, aggressive hyperkeratosis debridement, and tailored education before the integumentary barrier is breached. +-------------------------------------------------------------------------+
- | THE IWGDF RISK STRATIFICATION AND SURVEILLANCE CASCADE |
- +-------------------------------------------------------------------------+
- | CATEGORY 0: Very Low Risk (No LOPS, No PAD) |
- | --> Annual Clinical Surveillance |
- +-------------------------------------------------------------------------+
- | CATEGORY 1: Low Risk (Isolated LOPS OR Isolated PAD, No Deformity) |
- | --> Surveillance Every 6 to 12 Months |
- +-------------------------------------------------------------------------+
- | CATEGORY 2: Moderate Risk (LOPS + PAD, or LOPS/PAD + Deformity) |
- | --> Surveillance Every 3 to 6 Months |
- +-------------------------------------------------------------------------+
- | CATEGORY 3: High Risk (LOPS/PAD + Prior DFU, Amputation, or ESRD) |
- | --> Intensive Surveillance Every 1 to 3 Months |
- +-------------------------------------------------------------------------+
- The Four IWGDF Risk Categories in Clinical Practice
The IWGDF risk classification categorizes patients into four distinct tiers numbered 0 through 3. Each category reflects a quantifiable escalation in annual ulcer risk and dictates a mandatory clinical reassessment interval.
Category 0: Very Low Risk
Clinical Definition : A patient diagnosed with diabetes mellitus who demonstrates no Loss of Protective Sensation (LOPS) upon sensory testing and no Peripheral Artery Disease (PAD) upon objective vascular examination.
Pathophysiology : Afferent somatic sensory feedback remains intact. The patient maintains the physiological protective pain threshold required to perceive focal shear stresses, ill-fitting footwear, foreign objects, and thermal extremes. Microvascular and macrovascular perfusion is sufficient to meet normal metabolic and tissue repair demands.
Surveillance Frequency : Once annually .
Preventative Interventions : Annual comprehensive sensory and vascular screening, reinforcement of general diabetes control, baseline patient education regarding appropriate commercial footwear, and instructions to report unexpected foot trauma immediately.
Category 1: Low Risk
Clinical Definition : The presence of LOPS alone , OR the presence of PAD alone , in the absence of structural foot deformities.
Pathophysiology :
LOPS Alone : Distal symmetric sensorimotor polyneuropathy has silenced the patient's protective sensory warning system. Repetitive low-pressure cycles during walking generate cumulative mechanical strain that goes unperceived. However, in the absence of osseous deformities, ground reaction forces remain relatively well-distributed across the plantar vault.
PAD Alone : Atherosclerotic occlusive disease or microvascular impairment diminishes baseline arterial inflow, compromising cellular oxygenation and nutritional delivery, but the patient retains protective sensation and will alter gait patterns or footwear when experiencing discomfort.
Surveillance Frequency : Every 6 to 12 months .
Preventative Interventions : Evaluation of shoe fit to prevent friction, consideration of commercial extra-depth footwear, assessment of independent self-care abilities, and noninvasive vascular testing if PAD is identified.
Category 2: Moderate Risk
Clinical Definition : The presence of LOPS combined with PAD , OR the presence of LOPS combined with a structural foot deformity , OR the presence of PAD combined with a structural foot deformity .
Pathophysiology : This category captures dangerous synergistic risk profiles. When LOPS coexists with a structural deformity (such as claw toes, hammer toes, hallux valgus, prominent metatarsal heads, or rigid flatfoot), focal vertical ground reaction forces and shear stresses are multiplied by several hundred percent over discrete skeletal prominences. Because the patient cannot feel this localized tissue trauma, repetitive ambulation rapidly initiates subcutaneous microvascular occlusion, tissue ischemia, autolysis, and subkeratotic hematoma formation. Similarly, when PAD coexists with LOPS or deformity, impaired tissue perfusion drastically diminishes the skin's tolerance to mechanical pressure, accelerating necrosis.
Surveillance Frequency : Every 3 to 6 months .
Preventative Interventions : Prescription therapeutic extra-depth shoes, custom-molded total-contact insoles, regular sharp debridement of pre-ulcerative hyperkeratosis (calluses), gait evaluation, and early vascular or surgical consultation if perfusion is critically low or deformities are unaccommodated.
Category 3: High Risk
Clinical Definition : The presence of LOPS or PAD PLUS at least one of the following high-risk modifiers :
History of a prior diabetic foot ulcer (DFU)
History of a lower-extremity amputation (whether minor, such as a ray or toe resection, or major, such as transtibial or transfemoral)
Presence of End-Stage Renal Disease (ESRD) , particularly patients undergoing peritoneal dialysis or hemodialysis
Pathophysiology : Patients in Category 3 have demonstrated biological vulnerability to dermal breakdown or have sustained profound anatomical and biomechanical alterations. A healed ulcer site consists of non-pliable scar tissue (predominantly Type I collagen lacking original elastic fibers) with markedly reduced tensile strength (rarely exceeding 70% to 80% of uninjured skin). Amputations permanently alter gait mechanics and load-bearing vectors, shifting extreme compensatory peak pressures to adjacent metatarsal heads or the contralateral extremity. ESRD exacerbates risk through chronic uremic calcification of arterial medias (Mönckeberg sclerosis), autonomic failure, altered tissue hydration, and hypervolemia-induced peripheral edema.
Surveillance Frequency : Every 1 to 3 months .
Preventative Interventions : Intensive podiatric care, prescription specialized or custom-molded therapeutic footwear with rigid rocker soles, home skin temperature monitoring, frequent callus debridement, nephrology and vascular coordination, and family caregiver engagement.
The Standardized Surveillance Examination Protocol
At every scheduled surveillance visit, the clinician must execute a structured, standardized clinical examination protocol consisting of five core assessments: +-------------------------------------------------------------------------+
- | FIVE ESSENTIAL COMPONENTS OF FOOT SURVEILLANCE |
- +---+--------------------+------------------------------------------------+
- | 1 | SENSORY ASSESSMENT | 10-g Semmes-Weinstein Monofilament + Vibration |
- +---+--------------------+------------------------------------------------+
- | 2 | VASCULAR EXAM | Pedal pulses, CRT, dependent rubor, elevation |
- +---+--------------------+------------------------------------------------+
- | 3 | DERMATOLOGIC CHECK | Calluses, fissures, maceration, tinea pedis |
- +---+--------------------+------------------------------------------------+
- | 4 | MUSCULOSKELETAL | Claw/hammer toes, Charcot collapse, equinus |
- +---+--------------------+------------------------------------------------+
- | 5 | FOOTWEAR & ORTHOSES| Internal wear, foreign bodies, insole bottoming|
- +---+--------------------+------------------------------------------------+
- 1. Neurological Assessment for Loss of Protective Sensation (LOPS)
10-g Semmes-Weinstein Monofilament (Size 5.07) : The international gold standard for screening LOPS. When applied perpendicular to the skin until it buckles into a C-shape, it delivers exactly 10 grams of linear force. Testing must evaluate standardized plantar sites (minimally the plantar hallux, first metatarsal head, third metatarsal head, and fifth metatarsal head), avoiding calluses, scars, and open wounds. Use the chosen validated multi-site protocol with repeated applications and sham trials; classify LOPS from the protocol-defined pattern and a companion neurologic test rather than one uncertain response.
Vibratory and Reflex Testing : Application of a 128-Hz tuning fork over the bony prominence of the dorsal hallux interphalangeal joint, biothesiometer vibration perception threshold (VPT > 25 V indicates high risk), and Achilles deep tendon reflex testing assess large myelinated A-alpha and A-beta nerve fiber function.
2. Vascular Examination for Peripheral Artery Disease (PAD)
Palpation of Pedal Pulses : Bilateral palpation of the dorsalis pedis artery (on the dorsum of the foot between the first and second metatarsal bases) and the posterior tibial artery (posterior and inferior to the medial malleolus). Pulses are graded on a 0 to 4+ scale (0 = absent, 1+ = diminished, 2+ = normal, 3+ = bounding).
Physical Signs of Ischemia : Evaluation for dependent rubor, pallor on limb elevation, prolonged capillary refill time (> 2 to 3 seconds), absence of digital hair growth, dystrophic thickened nails, and thin, shiny, cool atrophic skin. If pulses are diminished or absent, objective noninvasive vascular testing—including Ankle-Brachial Index (ABI) and absolute Toe Pressure / Toe-Brachial Index (TBI)—is mandatory.
3. Dermatologic Inspection for Pre-Ulcerative Pathology
Complete visual inspection of the dorsal, plantar, medial, lateral, and interdigital surfaces under bright, direct illumination. The clinician must search actively for pre-ulcerative markers:
Hyperkeratotic Calluses : Rigid focal plaques that concentrate vertical ground reaction forces.
Subkeratotic Hemorrhage : Deep red, burgundy, or black discoloration beneath an intact callus, proving that dermal shearing and microvascular bleeding have already occurred.
Interdigital Maceration : White, soggy, softened skin between toes, frequently secondary to perspiration or untreated tinea pedis , which creates open portals for ascending bacterial cellulitis.
Heel Fissures : Deep cutaneous cracks through dry, anhidrotic skin that extend into the vascularized dermis.
4. Musculoskeletal and Biomechanical Examination
Identification of structural deformities that create abnormal focal pressure concentrations:
Claw Toes and Hammer Toes : Extensor-flexor imbalance causing MTP joint hyperextension and PIP/DIP flexion, creating high dorsal pressures against the shoe toe box and distal subluxation of the protective plantar fat pad away from the metatarsal heads.
Hallux Valgus (Bunions) : Medial deviation of the first metatarsal head and lateral deviation of the great toe, leading to prominent medial osseous friction.
Prominent Metatarsal Heads : Plantarflexed metatarsals that focalize ground impact.
Charcot Foot Deformity : Tarsometatarsal or midtarsal collapse producing a rigid "rocker-bottom" foot with profound midplantar osseous protrusions.
Ankle Equinus : Inability to dorsiflex the talocrural joint beyond neutral (0°) with the knee extended, dramatically increasing forefoot ground impact during terminal stance.
5. Footwear and Orthotic Surveillance
A comprehensive diabetic foot examination is incomplete without evaluating the patient's shoes and orthoses. The clinician must inspect:
Shoes for appropriate length (leaving 1/2 inch clearance beyond the longest toe) and width (matching the ball of the foot without compression).
The interior lining for torn seams, protruding stitching, or embedded foreign objects (e.g., small stones, needles, thumbtacks).
Outsoles for asymmetric or extreme wear patterns reflecting biomechanical abnormalities.
Custom insoles for permanent compression ("bottoming out") of cushioning layers such as Plastazote, which eliminates pressure-relieving efficacy.
Summary of IWGDF Categories and Surveillance Protocol
IWGDF Category Risk Level Clinical Criteria Minimum Surveillance Interval Core Clinical Interventions
0 Very Low No LOPS, No PAD Once annually Annual comprehensive screen; basic foot hygiene education; well-fitting commercial footwear.
1 Low LOPS alone, OR PAD alone (no deformity) Every 6 to 12 months Bi-annual screening; commercial extra-depth shoes if needed; home inspection education; vascular workup if PAD.
2 Moderate LOPS + PAD, OR LOPS + deformity, OR PAD + deformity Every 3 to 6 months Prescription extra-depth shoes; custom total-contact insoles; regular sharp callus debridement; biomechanical correction.
3 High LOPS or PAD PLUS prior DFU, amputation, or ESRD Every 1 to 3 months Prescription custom footwear with rocker soles; daily dermal infrared temperature monitoring; aggressive callus care; multidisciplinary team coordination.
Important
Clinical Scenario & Exam Trap: The "Fully Healed" Ulcer and Surveillance Downgrading A 58-year-old male with a 12-year history of Type 2 diabetes presents for follow-up. Eight months ago, he achieved complete epithelial closure of a neuropathic plantar ulcer over the second metatarsal head. Today, his HbA1c is 6.4%, monofilament testing confirms persistent bilateral LOPS, pedal pulses are palpable, and the previous ulcer site is covered by smooth, non-tender scar tissue with no open breakdown. The patient states, "My foot is completely healed and my blood sugar is great, so I only need to come back in a year for my annual checkup."
Exam Trap Insight : An inexperienced clinician might be tempted to downgrade this patient to Category 1 (LOPS alone) or Category 0 due to excellent current glycemic control and an intact skin envelope. This is a critical clinical error.
Under IWGDF criteria, a history of a prior diabetic foot ulcer permanently classifies the patient into Category 3 (High Risk) . Healed scar tissue lacks normal elastic fibers, possesses diminished vascularity, and achieves at most 70% to 80% of original tensile strength. Re-ulceration rates exceed 40% at 1 year and 65% at 3 to 5 years. Therefore, this patient requires intensive clinical surveillance every 1 to 3 months , maintenance of prescription therapeutic footwear with custom-molded orthoses, and daily home monitoring. A prior ulcer is an indelible risk marker that can never be downgraded.